Back to search

Article

Quantitative <i>in vivo</i> bioluminescence imaging of orthotopic patient-derived glioblastoma xenografts

2020-05-16

Abstract excerpt

Despite extensive research, little progress has been made in glioblastoma therapy, owing in part to a lack of adequate preclinical in vivo models to study this disease. To mitigate this, primary patient-derived cell lines, which maintain their specific stem-like phenotypes, have replaced established glioblastoma cell lines. However, due to heterogenous tumour growth inherent in glioblastoma, the use of primary ce...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
dae47021-4c43-5008-9a93-10a94545b936
DOI
10.1101/2020.05.15.098640
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Quantitative <i>in vivo</i> bioluminescence imaging of orthotopic patient-derived glioblastoma xenograftsDOI 10.1101/2020.05.15.098640
Select a neighboring publication to make it the new centre.